| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 09/06/2002 | WO2002046183A3 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 09/06/2002 | WO2002044170A3 Benzothiophene derivative compounds, process of preparation and use thereof |
| 09/06/2002 | WO2002042289A3 Process for preparing 3-aryl-benzo[b]thiophenes |
| 09/06/2002 | WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors |
| 09/06/2002 | WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/06/2002 | CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | CA2438895A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | CA2424768A1 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 09/05/2002 | US20020123630 Substituted benzopyran/quinoline or other heterobicyclic compounds useful for treating anxiety, depression, mania, drug abuse, epilepsy, Parkinson's disease, psychosis, migraine or cerebral ischaemia |
| 09/05/2002 | US20020123506 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 09/05/2002 | US20020123495 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 09/05/2002 | US20020123491 Selective neurokinin antagonists |
| 09/05/2002 | DE10109867A1 Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Use of triazole compounds for the prophylaxis and treatment of neurodegenerative diseases, brain trauma and cerebral ischemia |
| 09/05/2002 | DE10109866A1 Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Triazole compounds and their use for the prophylaxis and therapy of neurodegenerative diseases, brain trauma and cerebral ischaemia |
| 09/05/2002 | DE10109807A1 Verbrückte Diaminopyrazole und diese Verbindungen enthaltende Färbemittel Bridged diaminopyrazoles and colorants containing these compounds |
| 09/05/2002 | CA2337109A1 Herbicidal 2-pyrazolyl-6-aryloxypri(mi)dines |
| 09/04/2002 | EP1236719A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 09/04/2002 | EP1236460A1 Bridged diamino pyrazoles and colouring agents containing them |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235572A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 09/04/2002 | EP1140919B1 1,4-disubstituted cyclohexane derivatives for the treatment of depression |
| 09/04/2002 | EP1054886B1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 09/04/2002 | EP0991647B1 Eprosartan monohydrate |
| 09/04/2002 | EP0966444B1 Process for preparing pyrazole derivatives |
| 09/04/2002 | EP0906309B1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 09/04/2002 | EP0858459B1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives |
| 09/04/2002 | EP0642506B1 Heterocyclically bisubstituted sulphonyl amino(thio)carbonyl compounds |
| 09/04/2002 | CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists |
| 09/04/2002 | CN1367687A Calcilytic compounds |
| 09/04/2002 | CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090183C Sulphonylaminocarbonyltriazolinones with halogenated alk(EN)ylthio substituents |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444688 Compounds and compositions with nitrogen-containing non-basic side chains |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444616 Substituted p-trifluoromethylphenyluracils |
| 08/29/2002 | WO2002066470A1 Substituted alkylamine derivatives and methods of use |
| 08/29/2002 | WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066465A1 Water-soluble triazole fungicide |
| 08/29/2002 | WO2002066462A1 Pyrazole derivatives against tgf overexpression |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066459A1 Indole derivatives and their use as gnrh antagonists |
| 08/29/2002 | WO2002066456A2 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 08/29/2002 | WO2002066447A1 4h-1,2,4-triazole-3(2h)-thione deratives as sphingomyelinase inhibitors |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066443A2 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives |
| 08/29/2002 | WO2002066434A1 Oxime ether compound and agricultural or horticultural bactericide |
| 08/29/2002 | WO2002066036A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
| 08/29/2002 | WO2002066035A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/29/2002 | WO2002066034A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 08/29/2002 | WO2002026718A3 Bicyclic pyrimidin-4-one based inhibitors of factor xa |
| 08/29/2002 | WO2002002525A3 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 08/29/2002 | WO2001091807A3 Ethylenedicysteine (ec)-drug conjugates |
| 08/29/2002 | WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists |
| 08/29/2002 | WO2001017530A9 Iron chelators and uses thereof |
| 08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | US20020120145 Inhibiting farnesyl protein transferase. |
| 08/29/2002 | US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
| 08/29/2002 | US20020119994 LFA-1 Antagonist compounds |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119980 Antihistamines, antiallergens |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| 08/29/2002 | US20020119968 Protease inhibitor |
| 08/29/2002 | US20020119962 Novel urea compounds, compositions and methods of use and preparation |
| 08/29/2002 | DE10105866A1 Verfahren zur Herstellung von optisch aktiven, propargylischen, terminalen Epoxiden A process for preparing optically active, propargylic, terminal epoxides |
| 08/29/2002 | CA2438367A1 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 08/29/2002 | CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2438231A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
| 08/28/2002 | EP1234514A2 A reduced ignition propensity smoking article |
| 08/28/2002 | EP1233962A2 Novel heterocyclic compounds and their use as medicines |
| 08/28/2002 | EP1233769A1 Novel compounds |
| 08/28/2002 | EP0869785B1 4-hydroxycoumarin-3-carboxamides for the treatment of non-insulin dependent diabetes mellitus |
| 08/28/2002 | EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease |
| 08/28/2002 | CN1365972A Indole derivatives and its anticancer usage |
| 08/28/2002 | CN1089762C Benzimidazole compounds and their use as modulators of GABAA receptor complex |
| 08/28/2002 | CN1089761C Sidechain-bearing texanes and its preparing process |
| 08/27/2002 | US6441195 Substituted sulphonylamino(thio) carbonyl compounds |
| 08/27/2002 | US6441186 Epothilone analogs |
| 08/27/2002 | US6441030 3-phenyl-pyrones |
| 08/27/2002 | US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 08/27/2002 | US6441021 Type-iv collagenase inhibitors |
| 08/27/2002 | US6441018 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity |
| 08/27/2002 | US6441010 Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them |
| 08/27/2002 | US6441004 Monocyte chemoattractant protein-1 inhibitor compounds |
| 08/27/2002 | US6440995 Quinolin-4-yl derivatives |
| 08/27/2002 | US6440985 Methods for treating viral infections |